Bevatas 300mg Injection: Effective Medical Solution

Bevatas 300mg Injection

Description:

• Bevatas 300mg Injection is an anticancer medicine containing the active ingredient Bevacizumab.
• It is used to prevent the growth of tumors and is indicated in combination with other chemotherapy drugs to treat various types of cancer.

Uses:

• Glioblastoma multiforme (brain cancer).
• Persistent, recurrent, or metastatic breast cancer.
• Metastatic cervical cancer.
• Advanced kidney cancer.
• Metastatic colorectal cancer.
• Advanced non-small-cell lung cancer.
• Liver cancer (Hepatocellular carcinoma).
• Cancers of the ovary, cervical, fallopian tube, or primary peritoneal cancer.

Therapeutic Effects:

• Bevatas 300mg Injection is a recombinant humanized monoclonal antibody that works as a targeted therapy.
• It binds to the protein vascular endothelial growth factor A (VEGF-A), interrupting its interaction with receptors and inhibiting the formation of blood vessels that supply oxygen and nutrients to the tumor.

Administration:

• Administered intravenously by a physician or nurse.
• The infusion should be given immediately after dilution.

Safety Advice:

• Pregnancy: Inform your physician before starting treatment. The medicine may harm the unborn baby.
• Breastfeeding: Avoid breastfeeding for at least 6 months after treatment.
• Lungs: Inform your doctor if you have any lung conditions.
• Liver: Inform your physician if you have liver diseases.
• Alcohol: Consult your doctor about alcohol consumption during treatment.
• Driving: Avoid driving or using machinery due to possible dizziness or sleepiness.

Interaction with Other Drugs:

• Inform your doctor about all medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment.

Storage:

• Store Bevatas 300mg Injection at 2˚C to 8˚C. Do not freeze or shake.
• Protect from light. Keep out of reach of children.

Side Effects:

• Serious: Headache, vision changes, confusion, severe allergic reactions, high blood pressure, delayed wound healing following surgery, protein in urine, severe infections, blood clots, gut perforation, nosebleeds, heart problems, mouth sores.
• Common: Numbness in hands or feet, weakness, diarrhea, nausea, vomiting, abdominal pain, constipation, loss of appetite, weight loss, changes in taste and speech, decrease in white blood cell counts, fever, dry skin, back pain.

FAQs:

1. Is Bevatas 300mg Injection used as standalone treatment in cancers?
   • Bevatas 300mg Injection can be used as monotherapy or in combination with chemotherapy or immunotherapy medications.
2. Is it safe for women to use Bevatas 300mg Injection?
   • Women with reproductive potential should discuss effective birth control methods with their doctor during treatment and for at least 6 months after the course completion.
3. Is it safe to undergo surgery during the treatment with Bevatas 300mg Injection?
   • Avoid surgery during treatment due to the risk of bleeding complications and poor wound healing.
4. Do the side effects of Bevatas 300mg Injection last for a chronic period?
   • Side effects occur until the drug concentration stays in the body, which can be up to 4 months after the final dose.
5. How is Bevatas 300mg Injection administered?
   • Administered intravenously through infusion. The amount of drug is measured based on the patient’s body weight, height, and age.
6. Can I take Bevatas 300mg Injection if I am pregnant?
   • Inform your physician before starting treatment if you are pregnant or planning for pregnancy.

Fact Box:

• Molecule name: Bevacizumab.
• Therapeutic class: Anticancer.
• Pharmacological class: VEGF Inhibitor.

Tags: Bevatas_300mg, Injection, Medical_Injection, Drug_Product, Pharmaceutical_Product